19-7519261-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018083.5(ZNF358):āc.19G>Cā(p.Val7Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,613,696 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 31)
Exomes š: 0.000042 ( 1 hom. )
Consequence
ZNF358
NM_018083.5 missense
NM_018083.5 missense
Scores
1
3
12
Clinical Significance
Conservation
PhyloP100: 3.47
Genes affected
ZNF358 (HGNC:16838): (zinc finger protein 358) Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in several processes, including embryonic forelimb morphogenesis; neural tube development; and stem cell population maintenance. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06770167).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF358 | NM_018083.5 | c.19G>C | p.Val7Leu | missense_variant | 2/2 | ENST00000597229.2 | NP_060553.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF358 | ENST00000597229.2 | c.19G>C | p.Val7Leu | missense_variant | 2/2 | 2 | NM_018083.5 | ENSP00000472305.1 | ||
ENSG00000267952 | ENST00000599312.1 | c.117G>C | p.Trp39Cys | missense_variant | 2/2 | 2 | ENSP00000469588.1 | |||
ZNF358 | ENST00000596712.1 | c.19G>C | p.Val7Leu | missense_variant | 2/2 | 3 | ENSP00000472777.1 | |||
ENSG00000267952 | ENST00000597384.1 | n.273G>C | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151942Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
5
AN:
151942
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000762 AC: 19AN: 249358Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135350
GnomAD3 exomes
AF:
AC:
19
AN:
249358
Hom.:
AF XY:
AC XY:
16
AN XY:
135350
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461754Hom.: 1 Cov.: 36 AF XY: 0.0000646 AC XY: 47AN XY: 727190
GnomAD4 exome
AF:
AC:
62
AN:
1461754
Hom.:
Cov.:
36
AF XY:
AC XY:
47
AN XY:
727190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151942Hom.: 0 Cov.: 31 AF XY: 0.0000674 AC XY: 5AN XY: 74196
GnomAD4 genome
AF:
AC:
5
AN:
151942
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
74196
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
7
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2023 | The c.19G>C (p.V7L) alteration is located in exon 2 (coding exon 1) of the ZNF358 gene. This alteration results from a G to C substitution at nucleotide position 19, causing the valine (V) at amino acid position 7 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M
PrimateAI
Uncertain
T
Sift4G
Pathogenic
D;D
Polyphen
0.13
.;B
Vest4
0.53
MutPred
Loss of sheet (P = 0.0357);Loss of sheet (P = 0.0357);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at